The global probiotic supplement sales are expected to reach USD 7,524.6 million in 2024. It is projected to exhibit steady growth during the forecast period, with global demand for probiotic supplements rising at 11.2% CAGR. The market is projected to reach USD 23,874.5 million by 2034.
Attributes | Key Insights |
---|---|
Estimated Global Probiotic Market Size (2024E) | USD 7,524.6 million |
Projected Probiotic Supplement Market Value (2034F) | USD 23,874.5 million |
Value-based CAGR (2024 to 2034) | 11.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global probiotic supplement market grew at a significant CAGR from 2019 to 2023.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the estimated growth rates of several countries in the market. Brazil, China, and India are set to record high CAGRs of 9.1%, 9.0%, and 12.6%, respectively, through 2034.
Countries | Value-based CAGR (2024 to 2034) |
---|---|
United States | 8.1% |
Brazil | 9.1% |
United Kingdom | 8.5% |
China | 9.0% |
India | 12.6% |
By 2034, the United States is expected to surge at 8.1% CAGR. Consumers look for superior quality, safety, and efficacy in probiotic supplements. They are prompting companies to prioritize quality control and provide transparent information about their components and processes.
Consumers in the United States are becoming more aware of the importance of gut health and the role of probiotics in maintaining it, leading to a surging demand for probiotic supplements. Supplement’s with Flavors such as Berries, Peach and Mango are set to show higher sales over next few years
Probiotic supplement demand in China is anticipated to rise at a steady CAGR of 9.0% during the forecast period. The probiotic market is expanding due to increased accessibility through several retail channels, allowing customers to purchase products based on convenience and personal preferences.
The validation of probiotic ingredients-based supplements in China is enhancing research & development initiatives, improving medical understanding, and driving industry expansion.
The probiotic supplement market is projected to increase in India at a CAGR of 12.6% through 2034. Functional meals and beverages, such as yogurt, kefir, and probiotic injections, are gaining popularity among health-conscious customers due to their potential health benefits.
These items are fortified with probiotics, making them an easy way to incorporate probiotics into their diets. Manufacturers in India are incorporating probiotics into their products, creating innovative food and drink formulations. They are also offering specialized goods for specific demographics or medical needs.
The section below shows the saccharomyces segment dominating by bacteria type. The segment is expected to surge at a CAGR of 12.2% through 2034. Based on form, the capsule segment is anticipated to generate a dominant share through 2024. It is set to rise at a CAGR of 9.2% from 2024 to 2034.
Segment | Value-based CAGR (2024 to 2034) |
---|---|
Women (Customer Orientation w.r.t. Functionality) | 8.1% |
Saccharomyces (Bacteria Type) | 12.2% |
Health & Wellness Stores (Sales Channel) | 8.3% |
1 Billion to 5 Billion (CFU Count) | 7.2% |
Capsules (Form) | 9.2% |
Probiotic supplement manufacturers are actively working toward expanding the market and innovating their products. Leading players are taking key steps to meeting needs of quality and convenience while maintaining a competitive price. Key companies are directed toward mergers & acquisitions, partnerships, and collaborations to expand their market reach.
Key Industry Developments
The market is set to reach USD 7,524.6 million in 2024.
Demand for probiotic supplements is slated to expand at an 11.2% CAGR by 2034.
The market is set to reach USD 23,874.5 million in 2034.
Culturelle, Align, Billion Cheers, and Digestive Advantage are the key players.
Capsule segment is estimated to hold a significant market share in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Segmental Share Analysis
1.3. Dynamics Snapshot
1.4. Wheel of Fortune
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends by Region
3.5. Forecast Factors - Relevance & Impact
3.6. Regulations and Policies
4. Global Market - Pricing Analysis
4.1. Price Point Assessment by Region
4.1.1. Manufacturer Level Pricing
4.1.2. Distributor Level Pricing
4.2. Price Point Assessment by Customer Orientation w.r.t. Functionality
4.3. Price Forecast till 2034
5. Value Chain Analysis
5.1. Operating margins at each node of supply chain
5.2. List of Active Market Participants
6. Global Market Size in Value (US$ billion) and Volume (MT) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis, 2019 to 2023
6.2. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Customer Orientation w.r.t. Functionality
7.1. Introduction / Key Findings
7.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Customer Orientation w.r.t. Functionality, 2019 to 2023
7.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Customer Orientation w.r.t. Functionality, 2024 to 2034
7.4. Baby / Infant
7.4.1. Digestive Health
7.4.2. Metabolic Health
7.4.3. Immune Support
7.4.4. Others
7.5. Women
7.5.1. Digestive Health
7.5.2. Gut Brain Axis
7.5.3. Metabolic Health
7.5.4. Others
7.6. Men
7.6.1. Digestive Health
7.6.2. Gut Brain Axis
7.6.3. Metabolic Health
7.6.4. Others
7.7. Unisex
7.7.1. Digestive Health
7.7.2. Gut Brain Axis
7.7.3. Metabolic Health
7.7.4. Others
7.8. Market Attractiveness Analysis by Customer Orientation w.r.t. Functionality
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Bacteria Type
8.1. Introduction / Key Findings
8.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Bacteria Type, 2019 to 2023
8.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Bacteria Type, 2024 to 2034
8.3.1. Lactobacillus
8.3.2. Streptococcus
8.3.3. Bifidobacterium
8.3.4. Bacillus Coagulants
8.3.5. Saccharomyces
8.3.6. Lactococcus Lactis
8.4. Market Attractiveness Analysis by Bacteria Type
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Form
9.1. Introduction / Key Findings
9.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Form, 2019 to 2023
9.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Form, 2024 to 2034
9.3.1. Tablets / Pills
9.3.2. Capsules
9.3.3. Liquid
9.3.4. Powder
9.3.5. Gummies / Chewable
9.3.6. Lozenges
9.3.7. Others (Gels, Soft Gels)
9.4. Market Attractiveness Analysis by Form
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by CFU Count
10.1. Introduction / Key Findings
10.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by CFU Count, 2019 to 2023
10.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by CFU Count, 2024 to 2034
10.3.1. Less than 1 Billion
10.3.2. 1 Billion to 5 Billion
10.3.3. 5 Billion to 10 Billion
10.3.4. 10 Billion to 20 Billion
10.3.5. 20 Billion to 30 Billion
10.3.6. 30 Billion to 50 Billion
10.3.7. More than 50 Billion
10.4. Market Attractiveness Analysis by CFU Count
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Sales Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Sales Channel, 2019 to 2023
11.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Sales Channel, 2024 to 2034
11.3.1. Hypermarkets / Supermarkets
11.3.2. Specialty Stores
11.3.3. E-commerce
11.3.4. Drug Stores & Pharmacies
11.3.5. Health & Wellness Stores
11.3.6. Convenience Stores
11.3.7. Departmental Stores
11.3.8. Others
11.4. Market Attractiveness Analysis by Sales Channel
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
12.1. Introduction
12.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Region, 2019 to 2023
12.3. Current Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Region, 2024 to 2034
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis by Region
13. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
13.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
13.3.1. by Country
13.3.1.1. United States
13.3.1.2. Canada
13.3.2. by Customer Orientation w.r.t. Functionality
13.3.3. by Bacteria Type
13.3.4. by Form
13.3.5. by CFU Count
13.3.6. by Sales Channel
13.4. Market Attractiveness Analysis
13.4.1. by Country
13.4.2. by Customer Orientation w.r.t. Functionality
13.4.3. by Bacteria Type
13.4.4. by Form
13.4.5. by CFU Count
13.4.6. by Sales Channel
13.5. Key takeaways
14. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
14.3. Market Size (US$ billion) and Volume (MT) Forecast by Market Taxonomy, 2024 to 2034
14.3.1. by Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. by Customer Orientation w.r.t. Functionality
14.3.3. by Bacteria Type
14.3.4. by Form
14.3.5. by CFU Count
14.3.6. by Sales Channel
14.4. Market Attractiveness Analysis
14.4.1. by Country
14.4.2. by Customer Orientation w.r.t. Functionality
14.4.3. by Bacteria Type
14.4.4. by Form
14.4.5. by CFU Count
14.4.6. by Sales Channel
14.5. Key takeaways
15. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
15.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
15.3.1. by Country
15.3.1.1. Germany
15.3.1.2. United Kingdom
15.3.1.3. France
15.3.1.4. Italy
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Nordic
15.3.1.8. Russia
15.3.1.9. Poland
15.3.1.10. Rest of Europe
15.3.2. by Customer Orientation w.r.t. Functionality
15.3.3. by Bacteria Type
15.3.4. by Form
15.3.5. by CFU Count
15.3.6. by Sales Channel
15.4. Market Attractiveness Analysis
15.4.1. by Country
15.4.2. by Customer Orientation w.r.t. Functionality
15.4.3. by Bacteria Type
15.4.4. by Form
15.4.5. by CFU Count
15.4.6. by Sales Channel
15.5. Key takeaways
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
16.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
16.3.1. by Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. by Customer Orientation w.r.t. Functionality
16.3.3. by Bacteria Type
16.3.4. by Form
16.3.5. by CFU Count
16.3.6. by Sales Channel
16.4. Market Attractiveness Analysis
16.4.1. by Country
16.4.2. by Customer Orientation w.r.t. Functionality
16.4.3. by Bacteria Type
16.4.4. by Form
16.4.5. by CFU Count
16.4.6. by Sales Channel
16.5. Key takeaways
17. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ billion) and Volume (MT) Trend Analysis by Market Taxonomy, 2019 to 2023
17.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
17.3.1. by Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Malaysia
17.3.1.4. Indonesia
17.3.1.5. Vietnam
17.3.1.6. Philippines
17.3.1.7. Singapore
17.3.1.8. Rest of South Asia
17.3.2. by Customer Orientation w.r.t. Functionality
17.3.3. by Bacteria Type
17.3.4. by Form
17.3.5. by CFU Count
17.3.6. by Sales Channel
17.4. Market Attractiveness Analysis
17.4.1. by Country
17.4.2. by Customer Orientation w.r.t. Functionality
17.4.3. by Bacteria Type
17.4.4. by Form
17.4.5. by CFU Count
17.4.6. by Sales Channel
17.5. Key takeaways
18. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
18.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
18.3.1. by Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. by Customer Orientation w.r.t. Functionality
18.3.3. by Bacteria Type
18.3.4. by Form
18.3.5. by CFU Count
18.3.6. by Sales Channel
18.4. Market Attractiveness Analysis
18.4.1. by Country
18.4.2. by Customer Orientation w.r.t. Functionality
18.4.3. by Bacteria Type
18.4.4. by Form
18.4.5. by CFU Count by Sales Channel
18.5. Key takeaways
19. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
19.1. Introduction
19.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
19.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
19.3.1. by Country
19.3.1.1. GCC Countries
19.3.1.2. Turkiye
19.3.1.3. Egypt
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. by Customer Orientation w.r.t. Functionality
19.3.3. by Bacteria Type
19.3.4. by Form
19.3.5. by CFU Count
19.3.6. by Sales Channel
19.4. Market Attractiveness Analysis
19.4.1. by Country
19.4.2. by Customer Orientation w.r.t. Functionality
19.4.3. by Bacteria Type
19.4.4. by Form
19.4.5. by CFU Count
19.4.6. by Sales Channel
19.5. Key takeaways
20. Country-level Market Analysis, 2024
20.1. United States Market Analysis
20.1.1. by Customer Orientation w.r.t. Functionality
20.1.2. by Bacteria Type
20.1.3. by Form
20.1.4. by CFU Count
20.1.5. by Sales Channel
20.2. Canada Market Analysis
20.2.1. by Customer Orientation w.r.t. Functionality
20.2.2. by Bacteria Type
20.2.3. by Form
20.2.4. by CFU Count
20.2.5. by Sales Channel
20.3. Brazil Market Analysis
20.3.1. by Customer Orientation w.r.t. Functionality
20.3.2. by Bacteria Type
20.3.3. by Form
20.3.4. by CFU Count
20.3.5. by Sales Channel
20.4. Mexico Market Analysis
20.4.1. by Customer Orientation w.r.t. Functionality
20.4.2. by Bacteria Type
20.4.3. by Form
20.4.4. by CFU Count
20.4.5. by Sales Channel
20.5. Argentina Market Analysis
20.5.1. by Customer Orientation w.r.t. Functionality
20.5.2. by Bacteria Type
20.5.3. by Form
20.5.4. by CFU Count
20.5.5. by Sales Channel
20.6. Germany Market Analysis
20.6.1. by Customer Orientation w.r.t. Functionality
20.6.2. by Bacteria Type
20.6.3. by Form
20.6.4. by CFU Count
20.6.5. by Sales Channel
20.7. United Kingdom Market Analysis
20.7.1. by Customer Orientation w.r.t. Functionality
20.7.2. by Bacteria Type
20.7.3. by Form
20.7.4. by CFU Count
20.7.5. by Sales Channel
20.8. France Market Analysis
20.8.1. by Customer Orientation w.r.t. Functionality
20.8.2. by Bacteria Type
20.8.3. by Form
20.8.4. by CFU Count
20.8.5. by Sales Channel
20.9. Italy Market Analysis
20.9.1. by Customer Orientation w.r.t. Functionality
20.9.2. by Bacteria Type
20.9.3. by Form
20.9.4. by CFU Count
20.9.5. by Sales Channel
20.10. Spain Market Analysis
20.10.1. by Customer Orientation w.r.t. Functionality
20.10.2. by Bacteria Type
20.10.3. by Form
20.10.4. by CFU Count
20.10.5. by Sales Channel
20.11. BENELUX Market Analysis
20.11.1. by Customer Orientation w.r.t. Functionality
20.11.2. by Bacteria Type
20.11.3. by Form
20.11.4. by CFU Count
20.11.5. by Sales Channel
20.12. Nordic Market Analysis
20.12.1. by Customer Orientation w.r.t. Functionality
20.12.2. by Bacteria Type
20.12.3. by Form
20.12.4. by CFU Count
20.12.5. by Sales Channel
20.13. Russia Region Market Analysis
20.13.1. by Customer Orientation w.r.t. Functionality
20.13.2. by Bacteria Type
20.13.3. by Form
20.13.4. by CFU Count
20.13.5. by Sales Channel
20.14. Poland Market Analysis
20.14.1. by Customer Orientation w.r.t. Functionality
20.14.2. by Bacteria Type
20.14.3. by Form
20.14.4. by CFU Count
20.14.5. by Sales Channel
20.15. China Market Analysis
20.15.1. by Customer Orientation w.r.t. Functionality
20.15.2. by Bacteria Type
20.15.3. by Form
20.15.4. by CFU Count
20.15.5. by Sales Channel
20.16. Japan Market Analysis
20.16.1. by Customer Orientation w.r.t. Functionality
20.16.2. by Bacteria Type
20.16.3. by Form
20.16.4. by CFU Count
20.16.5. by Sales Channel
20.17. South Korea Market Analysis
20.17.1. by Customer Orientation w.r.t. Functionality
20.17.2. by Bacteria Type
20.17.3. by Form
20.17.4. by CFU Count
20.17.5. by Sales Channel
20.18. India Market Analysis
20.18.1. by Customer Orientation w.r.t. Functionality
20.18.2. by Bacteria Type
20.18.3. by Form
20.18.4. by CFU Count
20.18.5. by Sales Channel
20.19. Thailand Market Analysis
20.19.1. by Customer Orientation w.r.t. Functionality
20.19.2. by Bacteria Type
20.19.3. by Form
20.19.4. by CFU Count
20.19.5. by Sales Channel
20.20. Malaysia Market Analysis
20.20.1. by Customer Orientation w.r.t. Functionality
20.20.2. by Bacteria Type
20.20.3. by Form
20.20.4. by CFU Count
20.20.5. by Sales Channel
20.21. Indonesia Market Analysis
20.21.1. by Customer Orientation w.r.t. Functionality
20.21.2. by Bacteria Type
20.21.3. by Form
20.21.4. by CFU Count
20.21.5. by Sales Channel
20.22. Vietnam Market Analysis
20.22.1. by Customer Orientation w.r.t. Functionality
20.22.2. by Bacteria Type
20.22.3. by Form
20.22.4. by CFU Count
20.22.5. by Sales Channel
20.23. Philippines Market Analysis
20.23.1. by Customer Orientation w.r.t. Functionality
20.23.2. by Bacteria Type
20.23.3. by Form
20.23.4. by CFU Count
20.23.5. by Sales Channel
20.24. Singapore Market Analysis
20.24.1. by Customer Orientation w.r.t. Functionality
20.24.2. by Bacteria Type
20.24.3. by Form
20.24.4. by CFU Count
20.24.5. by Sales Channel
20.25. Australia Market Analysis
20.25.1. by Customer Orientation w.r.t. Functionality
20.25.2. by Bacteria Type
20.25.3. by Form
20.25.4. by CFU Count
20.25.5. by Sales Channel
20.26. New Zealand Market Analysis
20.26.1. by Customer Orientation w.r.t. Functionality
20.26.2. by Bacteria Type
20.26.3. by Form
20.26.4. by CFU Count
20.26.5. by Sales Channel
20.27. GCC Countries Market Analysis
20.27.1. by Customer Orientation w.r.t. Functionality
20.27.2. by Bacteria Type
20.27.3. by Form
20.27.4. by CFU Count
20.27.5. by Sales Channel
20.28. Turkiye Market Analysis
20.28.1. by Customer Orientation w.r.t. Functionality
20.28.2. by Bacteria Type
20.28.3. by Form
20.28.4. by CFU Count
20.28.5. by Sales Channel
20.29. Egypt Market Analysis
20.29.1. by Customer Orientation w.r.t. Functionality
20.29.2. by Bacteria Type
20.29.3. by Form
20.29.4. by CFU Count
20.29.5. by Sales Channel
20.30. South Africa Market Analysis
20.30.1. by Customer Orientation w.r.t. Functionality
20.30.2. by Bacteria Type
20.30.3. by Form
20.30.4. by CFU Count
20.30.5. by Sales Channel
21. Market Structure Analysis
21.1. Global Market Competition - a Dashboard View
21.2. Industry Structure Analysis
21.2.1. % tier 1 Market players
21.2.2. % tier 2 Market players
21.2.3. % tier 3 Market players
21.3. Global Market Company Share Analysis
21.3.1. For Tier 1 Market Players, 2024
21.3.2. Company Market Share Analysis of Top 5 Players, by Region
21.4. Key Participants Market Presence (Intensity Mapping) by Region
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Culturelle (i-Health, Inc.)
22.3.1.1. Source Portfolio
22.3.1.2. Source Claim
22.3.1.3. Revenue by Market Segments (Source/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Probiotic Supplementing Strategy
22.3.1.5.2. Source Strategy
22.3.1.5.3. Channel Strategy
22.3.1.6. SWOT Analysis
22.3.2. Align
22.3.3. Billion Cheers (Fermentis Life Sciences Pvt Ltd)
22.3.4. Digestive Advantage
22.3.5. Garden of Life (Nestle SA)
22.3.6. Spring Valley
22.3.7. Now Foods
22.3.8. Nature Made
22.3.9. HUM Nutrition Inc.
22.3.10. OLLY
22.3.11. Ora Organics
22.3.12. Natrol
22.3.13. Others (on additional request)
23. Assumptions and Acronyms
24. Research Methodology
Explore Food and Beverage Insights
View Reports